Advances in Development of Inhibitors of 17β-Hydroxysteroid Dehydrogenases
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
642-660
Author(s):
Donald Poirier
The Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma Multiforme and other Malignant Neoplasms
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
703-715
Author(s):
S. Loew, U. Schmidt, A. Unterberg and M.-E. Halatsch
Netrin and DCC: Axon Guidance Regulators at the Intersection of Nervous System Development and Cancer
Journal:
Current Drug Targets
Volume:
10
Page:
602-610
Author(s):
M. Duman-Scheel
Semaphorins at the Interface of Development and Cancer
Journal:
Current Drug Targets
Volume:
10
Page:
611-619
Author(s):
E. Flannery and M. Duman-Scheel
Functional Genomic Approaches Targeting the Wnt Signaling Network
Journal:
Current Drug Targets
Volume:
10
Page:
620-631
Author(s):
Ramanuj DasGupta
Fibroblast Growth Factors in Development and Cancer: Insights from the Mammary and Prostate Glands
Journal:
Current Drug Targets
Volume:
10
Page:
632-644
Author(s):
Kathryn L. Schwertfeger
Defining the Role of Integrin αvβ6 in Cancer
Journal:
Current Drug Targets
Volume:
10
Page:
645-652
Author(s):
A. Bandyopadhyay and S. Raghavan
Poly(ADP-Ribosylation): Beneficial Effects of Its Inhibition
Journal:
Current Enzyme Inhibition
Volume:
5
Page:
99-109
Author(s):
V. Giansanti, F. Dona and A. I. Scovassi
Serine Protease Inhibitor Kazal Type 1 (SPINK1): Beyond the Trypsin Inhibitor
Journal:
Current Enzyme Inhibition
Volume:
5
Page:
110-116
Author(s):
Masaki Ohmuraya, Nobuyuki Ozaki, Masahiko Hirota, Hideo Baba and Ken-ichi Yamamura
Peptides Targeting Angiogenesis Related Growth Factor Receptors
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2414-2429
Author(s):
Luca D. D'Andrea, Annarita Del Gatto, Lucia De Rosa, Alessandra Romanelli and Carlo Pedone